GeoVax Labs, Inc. (GOVXW)

Market Cap	17.47M
Revenue (ttm)	6.14M
Net Income (ttm)	-24.81M
Shares Out	25.36M
EPS (ttm)	-2.29
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	15,442
Open	0.0094
Previous Close	0.0080
Day's Range	0.0080 - 0.0094
52-Week Range	0.0077 - 0.4000
Beta	3.57
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About GOVXW

GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms in the United States. The company is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tumor cancers. It also developing GEO-CM04S1, a vacc...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1988
• Employees: 17
• Stock Exchange: NASDAQ
• Ticker Symbol: GOVXW
• Website: https://www.geovax.com